Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.0%

1 terminated out of 25 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

12%

3 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed with results

Key Signals

92% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (7)
P 4 (3)

Trial Status

Completed11
Unknown6
Enrolling By Invitation2
Active Not Recruiting2
Terminated1
Not Yet Recruiting1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07130968Enrolling By Invitation

Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform

NCT03892265Active Not Recruiting

A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti

NCT04295291Not Yet RecruitingPrimary

Quality of Cardiopulmonary Resuscitation Pre- and Intra Hospital

NCT06798961Active Not RecruitingPrimary

Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)

NCT05778981Recruiting

Endothelial Dysfunction and Non-cardiac Surgery

NCT05189847Completed

Clinical Register Studying the therApeutic Patient Population With Multifocal Atherosclerosis

NCT03118895Not ApplicableCompletedPrimary

Leaders Free III: BioFreedom™ Clinical Trial

NCT04548804Not ApplicableEnrolling By Invitation

Better Mechanistic Understanding of and Risk Stratification for Ventricular Tachyarrhythmias Through ECGI

NCT05654935Withdrawn

Telerobotic Ultrasound for Carotid Imaging - Feasibility Study

NCT04657393Not ApplicableTerminated

Ventilation in Cardiac Arrest

NCT04580992Unknown

Defining the Electrocardiographic Effect of Propofol on the Ajmaline Provocation Drug Challenge: A Prospective Trial

NCT01594073Completed

Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in Implantable Cardioverter-defibrillator (ICD) Therapy

NCT04547244Completed

CRTd Responders Optimization

NCT03307213Not ApplicableUnknown

BioFreedom QCA Study in CAD Patients

NCT03393793Completed

HEart trAnsplantation Registry of piTie-Salpetriere University Hospital

NCT03769740UnknownPrimary

Cerebral Oximetry and NIRS in Cardiac Arrest Patients

NCT01217528Not ApplicableCompletedPrimary

Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapies in Primary Prevention Patients

NCT01252823Not ApplicableCompleted

Implantable Loop Recorder in Hemodialysis Patients

NCT02298543Completed

Coronary Spasm Presenting Aborted Sudden Cardiac Death, the Multicenter Registry

NCT02446730Phase 4UnknownPrimary

Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome

Scroll to load more

Research Network

Activity Timeline